Raffles Medical Group Ltd

Raffles Medical Group Ltd

RAFLF
Raffles Medical Group LtdUS flagOther OTC
0.75
USD
- -
- -
1.38BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.21
0.22
0.24
0.27
0.27
0.27
0.29
0.31
0.39
0.44
0.38
0.4
0.41
0.29
Basic EPS, GAAP
0.05
0.04
0.04
0.04
0.04
0.04
0.03
0.04
0.05
0.08
0.05
0.03
0.04
0.03
Free Cash Flow per Basic Share
0.04
0.05
0.02
0.04
0.04
0.03
0.01
0.04
0.06
0.09
0.09
0.04
0.05
0.01
Dividend per Share
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.03
0.04
0.02
0.03
0.01
Book Value per Share
0.14
0.15
0.17
0.18
0.19
0.2
0.22
0.23
0.23
0.54
0.56
0.57
0.58
0.22
Tangible Book Value per Share
0.29
0.32
0.34
0.37
0.41
0.44
0.45
0.48
0.51
0.54
0.55
0.57
0.56
0.45
Basic Weighted Avg Shares
1,650
1,678
1,711
1,738
1,761
1,784
1,813
1,839
1,868
1,857
1,859
1,857
1,850
1,808
Sales/Revenue/Turnover
341
375
411
474
478
489
522
568
724
823
707
752
765
522
Operating Margin (%)
27.66
21.44
19.63
17.3
16.77
17.84
14.99
15.9
17.49
25.98
15.39
11.49
11.65
14.99
Depreciation Expense
8
10
13
15
15
18
29
35
39
40
38
43
45
29
Net Income, GAAP
85
68
69
70
71
71
60
66
84
143
90
62
71
60
Effective Tax Rate (%)
10.44
16.39
15.41
18.07
15.04
15.84
20.29
23.41
27.57
25.05
23.74
28.38
24.06
20.29
Profit Margin (%)
24.9
18.05
16.88
14.82
14.82
14.53
11.55
11.6
11.63
17.4
12.75
8.28
9.22
11.55
Working Capital
222
91
14
39
1
12
27
51
22
131
105
134
102
27
LT Debt
- -
7
21
17
38
97
181
166
92
77
82
72
27
181
Total Equity
474
540
622
682
752
817
857
914
977
1,028
1,044
1,065
1,056
857
Return on Invested Capital (%)
18.69
12.76
11.06
9.64
8.67
8.2
6.18
6.25
7.82
13.48
7.05
5.25
5.77
6.18
Return on Capital (%)
36.58
26.77
22.96
20.81
18.34
15.47
11.12
11.36
13.93
16.87
8.26
5.74
6.33
11.12
Return on Common Equity (%)
39
28.04
25.63
23.38
21.63
20.14
15.89
16.18
19.87
20.01
8.85
5.98
6.64
15.89

Capital Structure

FRC

in mil. unless spec.
Jun'19
Sep'19
Dec'19
ST Debt
16
16
19
LT Borrowings
116
119
157
LT Finance Leases
13
14
25
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,828
1,828
1,828
Market Capitalization
1,923
1,725
1,826

Working Capital

FRC

in mil. unless spec.
Jun'19
Sep'19
Dec'19
Total Current Assets
205
222
246
Cash, Cash Equivalents & STI
102
118
152
Accounts Receivable, Net
93
94
84
Inventories
10
10
10
Total Current Liabilities
200
213
219
Payables & Accruals
- -
- -
- -
ST Debt
16
16
19
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5.49%
2.96%
-0.85%
Free Cash Flow
54.13%
16.56%
39.73%
Net Income, GAAP
3.99%
8.65%
13.38%
Sales/Revenue/Turnover
6.93%
7.03%
1.83%
Total Cash Common Dividend
19.07%
27.34%
3.81%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
707
2024
- -
- -
- -
- -
752
2025
- -
- -
- -
- -
765

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.05
2024
- -
- -
- -
- -
0.03
2025
- -
- -
- -
- -
0.04

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.04
2024
- -
- -
- -
- -
0.02
2025
- -
- -
- -
- -
0.03

Company Description

APIChatGPT
CEO
Choon Yong Loo
Full Time Employees
2,965
Sector
Healthcare
Industry
Medical - Care Facilities
Address
585 North Bridge Road Singapore SE Singapore 188770
IPO Date
Feb 13, 2009
Business
Raffles Medical Group Ltd (RMG) is a leading integrated private healthcare provider in Asia that owns and operates Raffles Hospital, a tertiary care facility in Singapore with 24 specialist centres covering obstetrics and gynaecology, cardiology, oncology, orthopaedics and other disciplines; a network of over 100 multi-disciplinary clinics offering family medicine, specialist care, dental services, traditional Chinese medicine and diagnostics including medical laboratories and imaging; healthcare services through airport clinics at Changi and Hong Kong International Airports; hospitals and medical centres in China (Shanghai, Chongqing), Japan (Osaka), Hong Kong and Vietnam; a consumer healthcare division producing and distributing nutraceuticals, supplements, vitamins and diagnostic equipment under Raffles Health; and Raffles Health Insurance offering integrated shield plans, critical illness coverage and cancer protection riders. The group serves over 2.8 million patients annually and more than 7,000 corporate clients across primary care, hospital services, investment holdings and insurance segments, with operations spanning Singapore, China, Japan, Vietnam, Cambodia, Hong Kong and representative offices in Indonesia, Brunei and Bangladesh. Founded in 1976 and headquartered at Raffles Hospital in Singapore's central business district, RMG employs over 2,900 staff including more than 430 multi-specialty physicians. In 2025, the group signed strategic partnerships with Shanghai's Renji Hospital affiliated with Shanghai Jiao Tong University School of Medicine and Chongqing's First Affiliated Hospital to enhance cross-border medical cooperation, resource sharing and patient access under China's Healthy China 2030 strategy; entered a memorandum of understanding with Gene Solutions to expand oncology clinical trials and precision medicine via comprehensive genomic profiling; reported 1H2025 revenue growth of 3.5% to S$378.4 million and profit after tax up 5.0% to S$32.5 million with PATMI at S$32.1 million; revised its dividend policy to at least 50% of sustainable earnings and announced a share buyback of up to 100 million ordinary shares over two years; and appointed Ms Woo Yeng Yeng as chief financial officer while deepening leadership in China healthcare operations.

Company News

APIChatGPT
  • Raffles Medical Group Ltd (OTCMKTS:RAFLF) Short Interest Update

  • Raffles Medical Group (OTCMKTS:RAFLF) Trading 7.9% Higher – What’s Next?

  • Short Interest in Raffles Medical Group Ltd (OTCMKTS:RAFLF) Expands By 53,333.3%